Global Chronic Pain Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chronic Pain Treatment Market Research Report 2024
Chronic pain is pain that carries on for longer than 12 weeks despite medication or treatment. Most people get back to normal after pain following an injury or operation. But sometimes the pain carries on for longer or comes on without any history of an injury or operation.
According to Mr Accuracy reports new survey, global Chronic Pain Treatment market is projected to reach US$ 126790 million in 2029, increasing from US$ 79690 million in 2022, with the CAGR of 6.7% during the period of 2024 to 2029.
According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over the age of 60 will nearly double, from 12% to 22%. In addition, the prevalence of chronic pain in nursing home seniors is very high and has become a serious problem in nursing facilities. Globally, rising prevalence of chronic diseases is one of the major healthcare burdens, affecting high-income as well as low- and middle-income countries. Due to the increasing prevalence of chronic diseases, various treatments such as medication, physical therapy, and psychotherapy are widely used through which pain can be managed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chronic Pain Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Segment by Type
Drugs
Devices
Hospitals
Clinics
Nursing Homes
Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chronic Pain Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Chronic Pain Treatment market is projected to reach US$ 126790 million in 2029, increasing from US$ 79690 million in 2022, with the CAGR of 6.7% during the period of 2024 to 2029.
According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over the age of 60 will nearly double, from 12% to 22%. In addition, the prevalence of chronic pain in nursing home seniors is very high and has become a serious problem in nursing facilities. Globally, rising prevalence of chronic diseases is one of the major healthcare burdens, affecting high-income as well as low- and middle-income countries. Due to the increasing prevalence of chronic diseases, various treatments such as medication, physical therapy, and psychotherapy are widely used through which pain can be managed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chronic Pain Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Segment by Type
Drugs
Devices
Segment by Application
Hospitals
Clinics
Nursing Homes
Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chronic Pain Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source